Clinical Trial Update: Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response [NA]

View source ↗

Summary

Clinical trial update for a web-mediated follow-up in lymphoma patients at high risk of relapse; the study has terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Lymphoma Hodgkin
• Lymphoma Large B-cell Diffuse
• Lymphoma T-cell

Snippet

Sponsor: Weprom | Conditions: Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse | NA | Status: TERMINATED | Results posted: 2021-04-28